14 Results for "

WM

" in MedChemExpress (MCE) Product Catalog:
Products (14)

14 Results for "WM" in MCE Product Catalog:

15
15 Publications Verification
Art. -Nr.: HY-102058
CAS. Nr.: 2055397-28-7
Reinheit:  99.57%
Forschungsgebiete:  

Cancer

WM-1119, a chemical probe, is a highly potent and selective KAT6A inhibitor, with an IC50 of 0.25 μM for KAT6A in lymphoma cells, the binding KD values of WM-1119 with KAT6A, KAT5 and KAT7 are 2 nM, 2.2 μM, 0.5 μM , respectively .
loading...
    loading...
11
11 Cited Publications
Art. -Nr.: HY-134901
CAS. Nr.: 2229025-70-9
Reinheit:  99.78%
Forschungsgebiete:  

Cancer

WM-3835 is a potent and high-specific HBO1 (KAT7 or MYST2) inhibitor and binds directly to the acetyl-CoA binding site of HBO1. WM-3835 activates apoptosis while inhibits osteosarcoma (OS) cell proliferation, migration and invasion. WM-3835 has antitumor activity and potently inhibits pOS-1 xenograft growth in mice .
loading...
    loading...
4
4 Cited Publications
Art. -Nr.: HY-102060
CAS. Nr.: 2055397-18-5
Reinheit:  99.77%
Forschungsgebiete:  

Cancer

WM-8014 is an inhibitor of MOZ, a member of histone acetyltransferases, with an IC50 of 55 nM.
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-153728
CAS. Nr.: 2894832-05-2
Reinheit:  98.74%
Target:  

WDR5

Forschungsgebiete:  

Cancer

WM-586 is a covalent WDR5 inhibitor. WM-586 specifically decreases WDR5 and MYC interaction with an IC50 of 101 nM. WM-586 is used in research on a variety of cancers including neuroblastoma, breast cancer, bladder cancer and colorectal cancer .
loading...
    loading...
Art. -Nr.: HY-151561
CAS. Nr.: 2606990-92-3
Reinheit:  98.96%
Target:  

Parasite

Forschungsgebiete:  

Infection

WM382 is an orally active and potent dual plasmepsin IX/X (PMIX/X) inhibitor with IC50 values of 1.4 nM and 0.03 nM, respectively. WM382 has robust in vivo efficacy at multiple stages of the malaria parasite life cycle and an excellent resistance profile .
loading...
    loading...
Art. -Nr.: HY-154847
CAS. Nr.: 1308257-47-7
Reinheit:  99.48%
Target:  

WDR5

WM-662 is a WDR5-MYC interaction inhibitor, with an IC50 of 18 μM. WM-662 has potential for the research of cancer, aging, and neurodegenerative disorders .
loading...
    loading...
Art. -Nr.: HY-153728A
Reinheit:  99.07%
Target:  

WDR5

Forschungsgebiete:  

Others

(R)-WM-586 is the R-enantiomer of WM-586 .
loading...
    loading...
Art. -Nr.: HY-P991609
CAS. Nr.: 561063-60-3

Target:  

MMP

Forschungsgebiete:  

Cancer

ABX-MA1 is a humanized IgG2 monoclonal antibody inhibitor targeting MCAM/MUC18. ABX-MA1 significantly decreases homotypic aggregation and heterotypic adhesion to HUVECs, and the formation of experimental lung metastasis. ABX-MA1 potently inhibits tumor growth, angiogenesis, and MMP-2 expression in A375SM/WM2664 xenograft mice model, promising for melanoma research .
loading...
    loading...
Art. -Nr.: HY-18331
CAS. Nr.: 908027-55-4
Target:  

MDM-2/p53

Forschungsgebiete:  

Cancer

MI-219 is an antagonist for MDM2 with a Ki of 13.3 μM. MI-219 inhibits the MDM2-p53 interaction, inhibits thus the proliferation of FSCCL cells, with an IC50 of 2.5 μM .
loading...
    loading...
Art. -Nr.: HY-145314
Target:  

Integrin

Forschungsgebiete:  

Cancer

TC113 is a c(RGDyK)-Based conjugate of Gemcitabine (GEM). TC113 could be internalized by A549 cells through integrin αvβ3. TC113 shows potent antiproliferative properties against WM266.4 and A549 cells .
loading...
    loading...
Art. -Nr.: HY-102060R
CAS. Nr.: 2055397-18-5
Forschungsgebiete:  

Cancer

WM-8014 (Standard) is the analytical standard of WM-8014 (HY-102060). This product is intended for research and analytical applications. WM-8014 is an inhibitor of MOZ, a member of histone acetyltransferases, with an IC50 of 55 nM.
loading...
    loading...
Art. -Nr.: HY-102058R
CAS. Nr.: 2055397-28-7
Forschungsgebiete:  

Cancer

WM-1119 (Standard) is the analytical standard of WM-1119 (HY-102058). This product is intended for research and analytical applications. WM-1119, a chemical probe, is a highly potent and selective KAT6A inhibitor, with an IC50 of 0.25 μM for KAT6A in lymphoma cells, the binding Kd values of WM-1119 with KAT6A, KAT5 and KAT7 are 2 nM, 2.2 μM, 0.5 μM , respectively .
loading...
    loading...
Art. -Nr.: HY-N13739
CAS. Nr.: 75911-33-0
Taraxinic acid can be found in the roots of Taraxacum flavostylum and Taraxacum lucidum. It is a Tyrosinase inhibitor that dose-dependently inhibits Tyrosinase activity, showing approximately 54.5% inhibition at a concentration of 50 μg/mL. Taraxinic acid has an IC50 of 83.2 μM against melanoma cells A375 and HTB140, and an IC50 of 60.4 μM against melanoma cells WM793, with activity being both dose- and time-dependent. Taraxinic acid holds promise for research in the field of anticancer therapy .
loading...
    loading...
Art. -Nr.: HY-P992021

Forschungsgebiete:  

Cancer

WM-A1-3389 is an anti-human IGSF1monoclonal antibody and tumor growth inhibitor. WM-A1-3389 specifically binds to the C-terminus of IGSF1, increases secretion of Granzyme B, IFN?γ, and TNF?α, and inhibits growth of colon cancer or biliary tract cancer in xenogeneic or allogeneic mouse implantation models. WM-A1-3389 can be used for the research of colon cancer, biliary tract cancer, and head and neck cancer .
loading...
    loading...
  • 1